We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Risk Marker Found for Late-Life Depression

By LabMedica International staff writers
Posted on 22 Nov 2015
Print article
Image: Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer\'s disease and behavioral variant frontotemporal dementia (bvFTD) (Photo courtesy of Dr. Federica Agosta).
Image: Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer\'s disease and behavioral variant frontotemporal dementia (bvFTD) (Photo courtesy of Dr. Federica Agosta).
The epsilon 4 (ε4) allele of the apolipoprotein gene (APOE) has been associated with atherosclerosis as well as cardiovascular and cerebrovascular disease but it is less clear whether there is also an association with geriatric depression.

Individuals who carry the APOE ε4, one of the most powerful predictors in neuropsychiatry, are at increased risk for developing Alzheimer's disease, early age of Alzheimer's disease onset, and more rapid progression of Alzheimer's disease symptoms.

Scientists at the University of Gothenburg (Sweden) and their international colleagues enrolled 839 women and men with an age range, 70 to 92 years and a mean age, 73.8 years. The enrollees were free from dementia and depression that underwent neuropsychiatric and neuropsychological examinations and genotyping of the APOE ε4 allele. Follow-up evaluations were conducted in 2005 and 2009.The association between APOE ε4 allele and five year incidence of depression was examined, while avoiding possible confounding effects of clinical or preclinical dementia by excluding participants who had dementia at study entry, subsequently developed dementia during the nine year follow-up period.

Blood samples were collected, and APOE (gene map locus 19q13.2) genotyping was performed by minisequencing and was successful for 100% of the consenting participants. Genotypes were obtained for the two single nucleotide polymorphisms (rs7412 and rs429358) that are used to define unambiguously ε2, ε3, and ε4 alleles. Dementia was diagnosed by geriatric psychiatrists based on symptoms rated during the neuropsychiatric examinations and information from the close informant interviews.

In 2000, major depression was diagnosed in 32 participants, and minor depression was diagnosed in 94 participants. No associations could be observed at baseline between the APOE ε4 allele and minor depression. No interactions by sex regarding the association between depression and APOE ε4 could be seen and the presence of the APOE ε4 allele was not related to 5-year or 9-year mortality. However between 2000 and 2009, 103 individuals developed dementia; 50 new cases based on the 2005 examination, 53 new cases based on the 2009 examination. In a multiple logistic regression model (including age and sex), presence of the APOE ε4 allele was associated with dementia development during 2001to 2009.

Silke Kern, MD, PhD, the lead author of the study, said, “In our study, the presence of the APOE ε4 predicted future depression, even after excluding individuals who later developed dementia. It was also related to dementia. APOE ε4 might be a marker for identifying older persons at risk to develop depression or dementia, which could be important for prevention and early detection of these common disorders.” The study was published on November 15, 2015, in the journal Biological Psychiatry.

Related Links:

University of Gothenburg


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.